Anita Chawla

Senior Advisor @Analysis Group

Menlo Park, CA, US
MOBILE NUMBERS
+13•••••••99

Signup · Get unlimited contacts

WORK HISTORY

Jul 2020 — Present

Senior Advisor @Analysis Group

View department →

Menlo Park, CA, US

EDUCATION

N/A

Wellesley College

BA, Economics and Political Science

N/A

University of Michigan

PhD, Economics

SKILLS

Data AnalysisClinical DevelopmentVenture CapitalHealthcareManagementSasClinical TrialsClinical ResearchAnalysisPharmaceutical IndustryMarket AccessHealth EconomicsCommercializationBiotechnologyAnalyticsBusiness StrategyResearchOncologyEconomicsFinancial ModelingOutcomes ResearchDue DiligenceStatisticsCross-Functional Team LeadershipEconometricsStrategy

ABOUT ANITA CHAWLA

Dr. Chawla has more than 25 years of experience as an economist in the health care sector. Since joining Analysis Group in 2007, she has helped global biopharmaceutical, diagnostic, and medical device manufacturers-as well as development-stage companies-address product development and commercialization objectives, particularly as they relate to market access. Her work has spanned a wide range of therapeutic areas, including multiple indications in oncology. Her recent client work includes landscape assessments, economic modeling, and strategic plans to inform evidence generation in the context of product development and market access launch strategy; forecasts to help prioritize research and support licensing and venture funding discussions; payer research and advisory boards; and launch materials that communicate a product\'s clinical and economic value to support evidence-based reviews. Dr. Chawla recently led an engagement comprising a fully integrated market access strategy and related tactics to support the launch of a novel drug to treat an orphan disease. Dr. Chawla\'s recent publications include an assessment of the impact of regulatory requirements for cardiovascular risk evaluation for diabetes therapies, and a study estimating the expected net present value of a weight-management drug entering pre-clinical trials given a range of scenarios representing evolving expectations of development costs, revenue, and litigation risk over the past 25 years.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Anita Chawla — Email, Phone Number & Contact Info | Unifers